Table 3 Empiric antibiotics therapy of 781 patients with IPD from different regions of China
|  | All Patients n = 781 | North n = 349 | East n = 158 | South n = 236 | Northwest n = 38 | p* |
|---|---|---|---|---|---|---|
Penicillins monotherapy | 64 (8.2) | 18 (5.2) | 23 (14.6) | 21 (8.9) | 2 (5.3) | 0.006 |
Cephalosporin monotherapy | 427 (54.7) | 199 (57.0) | 78 (49.4) | 131 (55.5) | 19 (50.0) | 0.396 |
Carbapenem monotherapy | 90 (11.5) | 43 (12.3) | 17 (10.8) | 25 (10.6) | 5 (13.2) | 0.895 |
Cephalosporin plus vancomycin | 52 (6.7) | 25 (7.2) | 7 (4.4) | 18 (7.6) | 2 (5.3) | 0.566 |
Carbapenem plus vancomycin | 122 (15.6) | 47 (13.5) | 29 (18.4) | 36 (15.3) | 10 (26.3) | 0.142 |
Cephalosporin plus linezolid | 5 (0.6) | 4 (1.1) | 0 (0) | 1 (0.4) | 0 (0) | 0.278 |
Carbapenem plus linezolid | 7 (0.9) | 5 (1.4) | 1 (0.6) | 1 (0.4) | 0 (0) | 0.475 |
Cephalosporin plus teicoplanin | 3 (0.4) | 3 (0.9) | 0 (0) | 0 (0) | 0 (0) | 0.183 |
Macrolides monotherapy | 11 (1.4) | 5 (1.4) | 3 (1.9) | 3 (1.3) | 0 (0) | 0.715 |